[go: up one dir, main page]

LU92749I2 - Composition comprenant le virus de la diarrhée virale bovine atténué 1(bvdv-1) et le virus de la diarrhée virale bovine atténué 2 (bvdv-2) - Google Patents

Composition comprenant le virus de la diarrhée virale bovine atténué 1(bvdv-1) et le virus de la diarrhée virale bovine atténué 2 (bvdv-2) Download PDF

Info

Publication number
LU92749I2
LU92749I2 LU92749C LU92749C LU92749I2 LU 92749 I2 LU92749 I2 LU 92749I2 LU 92749 C LU92749 C LU 92749C LU 92749 C LU92749 C LU 92749C LU 92749 I2 LU92749 I2 LU 92749I2
Authority
LU
Luxembourg
Prior art keywords
bvdv
diarrhea virus
bovine viral
viral diarrhea
attenuated bovine
Prior art date
Application number
LU92749C
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34967522&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU92749(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of LU92749I2 publication Critical patent/LU92749I2/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24361—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LU92749C 2004-05-19 2015-06-19 Composition comprenant le virus de la diarrhée virale bovine atténué 1(bvdv-1) et le virus de la diarrhée virale bovine atténué 2 (bvdv-2) LU92749I2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004025452A DE102004025452A1 (de) 2004-05-19 2004-05-19 Vakzine enthaltend BVDV

Publications (1)

Publication Number Publication Date
LU92749I2 true LU92749I2 (fr) 2015-11-02

Family

ID=34967522

Family Applications (3)

Application Number Title Priority Date Filing Date
LU92747C LU92747I2 (fr) 2004-05-19 2015-06-19 Virus de la diarrhée bovine atténué 1 (bvdv-1)
LU92749C LU92749I2 (fr) 2004-05-19 2015-06-19 Composition comprenant le virus de la diarrhée virale bovine atténué 1(bvdv-1) et le virus de la diarrhée virale bovine atténué 2 (bvdv-2)
LU92748C LU92748I2 (fr) 2004-05-19 2015-06-19 Virus de la diarrhée virale bovine atténué 2 (bvdv-2)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
LU92747C LU92747I2 (fr) 2004-05-19 2015-06-19 Virus de la diarrhée bovine atténué 1 (bvdv-1)

Family Applications After (1)

Application Number Title Priority Date Filing Date
LU92748C LU92748I2 (fr) 2004-05-19 2015-06-19 Virus de la diarrhée virale bovine atténué 2 (bvdv-2)

Country Status (26)

Country Link
EP (1) EP1751276B9 (fr)
JP (2) JP5006782B2 (fr)
KR (1) KR100908798B1 (fr)
CN (2) CN103352030B (fr)
AR (2) AR049176A1 (fr)
AT (1) ATE420949T1 (fr)
AU (1) AU2005243488B2 (fr)
BR (1) BRPI0510396B1 (fr)
CA (1) CA2561719C (fr)
CY (4) CY1109036T1 (fr)
DE (2) DE102004025452A1 (fr)
DK (1) DK1751276T5 (fr)
ES (1) ES2321210T3 (fr)
FR (3) FR15C0043I2 (fr)
HU (2) HUS1500033I1 (fr)
LU (3) LU92747I2 (fr)
ME (1) ME01119B (fr)
MX (1) MXPA06013298A (fr)
NL (3) NL300744I2 (fr)
NZ (1) NZ552088A (fr)
PL (1) PL1751276T3 (fr)
PT (1) PT1751276E (fr)
RS (1) RS50753B9 (fr)
SI (1) SI1751276T1 (fr)
UY (1) UY28905A1 (fr)
WO (1) WO2005111201A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
US20090068223A1 (en) * 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
AR062917A1 (es) * 2006-09-22 2008-12-17 Intervet Int Bv Nuevo mutante de pestivirus para uso en una vacuna.
AR069087A1 (es) 2007-10-29 2009-12-30 Boehringer Ingelheim Vetmed Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma
UY31930A (es) 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
WO2010051210A1 (fr) 2008-10-31 2010-05-06 Boehringer Ingelheim Vetmedica, Inc. Utilisation de divers antigènes y compris des antigènes provenant de mycoplasma bovis dans une composition de vaccin multivalente
US8846054B2 (en) 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
UY32570A (es) 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
ES2606605T3 (es) * 2010-09-21 2017-03-24 Intervet International B.V. Vacuna para el BVDV
JP6589159B2 (ja) * 2014-04-01 2019-10-16 共立製薬株式会社 新規ネコモルビリウイルス株、不活化ワクチン製剤、並びにネコモルビリウイルス感染症予防方法
DK3146042T3 (da) * 2014-05-23 2019-09-30 Boehringer Ingelheim Vetmedica Gmbh Rekombinant klassisk svinepestvirus (CSFV) med substitution i E2-proteinets TAV-epitop
CN105779499B (zh) * 2016-03-23 2019-11-19 江苏科技大学 重组杆状病毒和其应用及构建该重组杆状病毒的载体
CN107823639B (zh) * 2017-11-10 2020-10-02 齐鲁动物保健品有限公司 牛病毒性腹泻病毒灭活疫苗及其制备方法
CN108707190B (zh) * 2018-04-18 2021-07-13 中国科学院武汉病毒研究所 猪瘟病毒ns5b蛋白保真度突变体及其应用
CN114853912B (zh) * 2022-05-24 2023-06-13 中国农业科学院兰州兽医研究所 一种牛病毒性腹泻病毒e2-e0融合蛋白、制备方法及应用
CN115960847B (zh) * 2023-01-11 2024-06-14 青岛大学 小分子依赖的内含肽自剪接系统在制备减毒活疫苗中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6168942B1 (en) * 1998-11-10 2001-01-02 Pfizer Inc. Attenuated forms of bovine viral diarrhea virus
EP1104676A1 (fr) * 1999-11-30 2001-06-06 Boehringer Ingelheim Vetmedica Gmbh Virus de la diarrhée des bovins surs attenués pour utilisation chez des vaches gravides
CA2363493C (fr) * 2000-11-22 2006-06-06 Xuemei Cao Virus de la diarrhee virale bovine de formes attenuees
DE10143813A1 (de) * 2001-09-06 2003-04-10 Boehringer Ingelheim Vetmed Infektiöser Rindervirusdiarrhoe-Virusklon

Also Published As

Publication number Publication date
HUS1500033I1 (hu) 2015-07-28
CY2015021I2 (el) 2023-11-15
KR20070012862A (ko) 2007-01-29
NL300743I1 (fr) 2016-01-26
CN1989240B (zh) 2013-07-31
JP5006782B2 (ja) 2012-08-22
RS50753B (sr) 2010-08-31
BRPI0510396A (pt) 2007-11-13
CN103352030A (zh) 2013-10-16
CY2015022I1 (el) 2020-05-29
DK1751276T5 (da) 2020-07-20
CA2561719C (fr) 2015-01-27
JP2007537740A (ja) 2007-12-27
CA2561719A1 (fr) 2005-11-24
CN1989240A (zh) 2007-06-27
HUS1500031I1 (hu) 2019-11-28
NL300744I1 (fr) 2016-01-26
DE102004025452A1 (de) 2006-01-19
ES2321210T9 (es) 2020-11-04
RS50753B9 (sr) 2020-08-31
ATE420949T1 (de) 2009-01-15
ME01119B (me) 2013-03-20
CY2015023I2 (el) 2024-02-16
SI1751276T1 (sl) 2009-06-30
CY1109036T1 (el) 2014-07-02
FR15C0044I1 (fr) 2015-07-24
NL300745I2 (fr) 2016-01-26
AU2005243488B2 (en) 2011-07-07
ES2321210T3 (es) 2009-06-03
FR15C0043I1 (fr) 2015-07-24
FR15C0042I2 (fr) 2018-11-16
UY28905A1 (es) 2005-12-30
WO2005111201A1 (fr) 2005-11-24
NZ552088A (en) 2009-10-30
MXPA06013298A (es) 2007-05-07
LU92747I2 (fr) 2015-11-02
CY2015021I1 (el) 2020-05-29
DK1751276T3 (da) 2009-05-18
PT1751276E (pt) 2009-02-24
EP1751276B1 (fr) 2009-01-14
EP1751276A1 (fr) 2007-02-14
FR15C0042I1 (fr) 2015-07-24
AR049176A1 (es) 2006-07-05
JP5562316B2 (ja) 2014-07-30
NL300743I2 (fr) 2016-01-26
KR100908798B1 (ko) 2009-07-22
BRPI0510396B1 (pt) 2020-08-18
FR15C0043I2 (fr) 2016-05-27
AU2005243488A1 (en) 2005-11-24
DE602005012381D1 (de) 2009-03-05
EP1751276B9 (fr) 2020-05-27
CN103352030B (zh) 2018-08-10
LU92748I2 (fr) 2015-11-02
JP2012061001A (ja) 2012-03-29
CY2015022I2 (el) 2024-02-16
AR104448A2 (es) 2017-07-19
NL300744I2 (fr) 2016-01-26
PL1751276T3 (pl) 2009-06-30
NL300745I1 (fr) 2016-01-26
FR15C0044I2 (fr) 2016-05-27
CY2015023I1 (el) 2020-05-29

Similar Documents

Publication Publication Date Title
LU92749I2 (fr) Composition comprenant le virus de la diarrhée virale bovine atténué 1(bvdv-1) et le virus de la diarrhée virale bovine atténué 2 (bvdv-2)
DE60045394D1 (de) Zusammensetzungen gegen infektionen zur behandlung erkrankten gewebes wie z.b. fieberbläschen
FR20C1016I1 (fr)
BRPI0309631A2 (pt) vacina tetravalente da dengue contendo uma trivial deleção de 30 nucleotídeos na utr-31' dos tipos de dengue 1,2,3,e 4, ou de vírus antigênicos quiméricos da dengue 1,2,3 e 4
DK1173441T3 (da) 6-alkenyl-, 6-alkynyl- og 6-epoxy-epothilon-derivater, fremgangsmåde til fremstilling af disse samt deres anvendelse i farmaceutiske sammensætninger
ATE364386T1 (de) (s,s)-reboxetine zur behandlung von chronischen erschöpfungssyndrom
EP1317253A4 (fr) Composant biologique comprenant une membrane artificielle
NO2012018I1 (no) Canakinumab eller direkte ekvivalenter derav
DK1181027T3 (da) Diætetisk eller farmaceutisk præparat til anvendelse til forebyggelsen eller behandling af hyperoxaluri
NL1013685A1 (nl) Verknopingsmiddel voor fotolaklaag en fotolaklaagsamenstelling welke deze omvat.
DE60138711D1 (de) Antikörper gegen il-12, zusammensetzungen, verfahren und verwendungen
FR2869217B1 (fr) Implant glenoidien pour prothese totale d'epaule inversee, et prothese totale d'epaule inversee le comprenant
IL209342A (en) Nucleic acid chimera composed of West Nile virus and dengue fever virus, preparations containing them and their uses
NO20052363L (no) Interferon-alfa polypeptider og konjugater
IS6378A (is) Efnasambönd og samsetningar gegn dvergveirum, notkun þeirra til lyfjagerðar og efni til að framleiða þau
DK1315709T3 (da) Aminoalkylbenzoyl-benzofuraner eller benzothiophener, fremgangsmåde til fremstilling deraf og sammensætninger indeholdende samme
NL1013684A1 (nl) Verknopingsmiddel voor fotolaklaag, en fotolaklaagsamenstelling welke dezelfde omvat.
DK1749885T3 (da) Infektiøs og svækket kvægdiarévirus
DK1377316T3 (da) Farmaceutisk sammensætning på grundlag af azalider til lokal anvendelse i oftalmologien
FR2833599B1 (fr) Polysaccharide amphotere, composition et utilisation
AU2002365269A8 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
DE60114039D1 (de) Kautschukzusammensetzungen und vulkanisate einschliesslich verzweigter kammpolymere
ZA200703762B (en) Mutant porcine reproductive and respiratory syndrome virus
ITRM20010116A0 (it) Indicatore goniometricoastronomico, in particolare solare e/o lunare.
IT1313700B1 (it) Composizioni anti-incrostazione e loro impiego nei processi dipolimerizzazione.